Document Detail


Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface.
MedLine Citation:
PMID:  7584115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To evaluate the ability of genetically modified peritoneal mesothelial cells to deliver recombinant proteins to the systemic circulation, we used our previously described mesothelial cell-based ex vivo gene therapy strategy. Rat primary peritoneal mesothelial cells, isolated from parietal peritoneum by enzymatic digestion, were stably transfected (using strontium phosphate DNA co-precipitation) with the plasmid pSVTKgh to express a secreted reporter gene product, human growth hormone (hgh). Such hgh-secreting mesothelial cells were reseeded on the denuded peritoneal surface of syngeneic recipients and delivery of the reporter gene product to the systemic circulation was monitored by analysis of serum samples for the presence of hgh at various times after mesothelial cell implantation. Polymerase chain reaction (PCR) analysis demonstrated that the hgh-transfected mesothelial cells repopulated the denuded areas and remained attached there for at least 12 weeks. Moreover, these genetically modified mesothelial cells continued to express the reporter gene product in vivo and secreted hgh in sufficient quantity to be detected in the systemic circulation (ie statistically significant amounts of hgh could be measured in the serum of cyclosporine A-treated rats for at least 2 months; Mann-Whitney test, P < 0.05). Our results demonstrate the successful, sustained, systemic delivery of a recombinant protein by genetically modified peritoneal mesothelial cells following their reattachment to the peritoneal surface, and suggest the potential of ex vivo mesothelial cell-mediated gene therapy for the treatment of inherited or acquired disorders requiring delivery of therapeutic proteins to the circulation.
Authors:
J A Nagy; T R Shockley; E M Masse; V S Harvey; C M Hoff; R W Jackman
Related Documents :
9654195 - Increased prosomal proteins in breast cancer cells and in neighboring normal cells in p...
21304935 - Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perf...
22770525 - Wrapping tissues with a pre-established cage-like layer composed of living cells.
1943875 - Pathway to carcinogenesis: the role of bacterial spores.
2081015 - Evidence for a dioa-sensitive [k+,cl-]-cotransport system in cultured vascular smooth m...
23582235 - Zinc promotes the death of hypoxic astrocytes by upregulating hypoxia-induced hypoxia-i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gene therapy     Volume:  2     ISSN:  0969-7128     ISO Abbreviation:  Gene Ther.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-12-04     Completed Date:  1995-12-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421525     Medline TA:  Gene Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  402-10     Citation Subset:  IM    
Affiliation:
Department of Pathology, Beth Israel Hospital, Boston, MA 02215, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Base Sequence
DNA Primers
Epithelial Cells
Epithelium / metabolism,  transplantation
Female
Gene Therapy / methods*
Growth Hormone / biosynthesis*,  blood
Humans
Kanamycin Kinase
Molecular Sequence Data
Peritoneum
Phosphotransferases (Alcohol Group Acceptor) / biosynthesis
Polymerase Chain Reaction / methods
Rats
Rats, Inbred F344
Recombinant Proteins / biosynthesis*,  blood
Transfection*
Chemical
Reg. No./Substance:
0/DNA Primers; 0/Recombinant Proteins; 9002-72-6/Growth Hormone; EC 2.7.1.-/Phosphotransferases (Alcohol Group Acceptor); EC 2.7.1.95/Kanamycin Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mesothelial cell-mediated gene therapy: feasibility of an ex vivo strategy.
Next Document:  Organoids direct systemic expression of erythropoietin in mice.